Tertiary ICU
Multi-channel infusion, tracheostomy readiness and Level 1 warming for trauma and transplant pathways.
CLINICAL APPLICATIONS
From ICU airway carts to home infusion protocols.
Smiths Medical maps respiratory, infusion and vascular access requirements to the care setting that owns the workflow—not a generic hospital silhouette.
CARE-SETTING PILLARS
Six horizontal stories procurement teams use in RFPs.
Operating rooms
Portex airway kits, fluid warmers and syringe pumps coordinated with anesthesia drug libraries.
Ambulatory surgery
High-turnover vascular access and short-stay infusion with CSSD single-use economics.
Emergency departments
Rapid-gauge IV selection, HME circuits and crash-cart warmer readiness under time pressure.
Home infusion
CADD ambulatory protocols, caregiver training and remote alarm escalation without clinic presence.
Long-term care
Acapella therapy, tracheostomy supplies and infection-control consumables for chronic airway programs.
CASE SNAPSHOTS
What changed after reference-level deployment.
1,100-bed academic medical center
Medfusion syringe fleet standardization cut pharmacy library exceptions by 29% in nine months after a controlled IEC 62304 update window. Results are cohort-specific and not a guarantee for every campus.
Regional ASC network
Jelco ProtectIV Plus formulary alignment reduced gauge mismatch scrap and sharps incidents reported to infection prevention when nursing competency and unique device identification (UDI) receiving checks stayed in place.
Home infusion pharmacy
CADD Solis protocol packs with teach-back checklists lowered first-week pump-related nurse call-backs across three states when caregiver training matched the current IFU revision.
SELECTION TRADE-OFF
Single-use airway and vascular consumables vs reusable reprocessing programs.
Infection prevention and sustainability committees often pull in opposite directions. Smiths Medical documentation supports either path only when the exact reference, Spaulding class and market labeling are confirmed.
| Decision field | Single-use disposables | Reusable / reprocessed pathway |
|---|---|---|
| Sterility & liability | Factory sterility assurance level (SAL) where labeled; removes on-site reprocessing liability for that SKU | Depends on validated ISO 17664 / ANSI/AAMI ST91 processes; Spaulding misclassification remains a site risk |
| Economics | Predictable per-procedure cost; higher consumable spend in high-turnover ASC lanes | Lower cost per use after capital and CSSD labor are amortized—only if cycle volume is stable |
| Sustainability | Higher waste footprint; simpler turnaround when CSSD capacity is constrained | Lower waste when reprocessing validation, water/energy use and device end-of-life are governed |
| Documentation needed | IFU, UDI DI/PI, biocompatibility testing class, sterile barrier symbols, lot/expiry receiving checklist | Reprocessing IFU, validation report, post-market surveillance (PMS) feedback loop and device master record (DMR) scope match |
Do not mix single-use and reprocessed instructions for the same catalog reference. Market-specific labeling always controls.
